Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00288808 · ClinicalTrials.gov registry record · Phase 1
Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.
A Phase 1 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
NCT00288808 is a Phase 1 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 200 participants.
The verdict
NCT00288808, a Phase 1 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
Study Summary
Investigate the validity of Hemosense System in pediatric patients on anticoagulation therapy.
Interventions
- DEVICE Hemosense (PT/InR point of care device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00288808
The ClinicalTrials.gov registry entry for NCT00288808 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hemosense (PT/InR point of care device) is the first listed.
NCT00288808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00288808 about?
NCT00288808 is a clinical study titled "Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.". Investigate the validity of Hemosense System in pediatric patients on anticoagulation therapy.
What is the current status of trial NCT00288808?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2005-10. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00288808?
The interventions under investigation include: Hemosense (PT/InR point of care device) (DEVICE).
Who is sponsoring clinical trial NCT00288808?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.